Arnouk SM, Kancheva D, Van Damme H, Courtoy GE, et al. Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy. Cancer Res 2025;85:4681-4700.
PMID: 40960523